Table 3

Univariate and multivariate analysis of hK6 and other clinicopathological characteristics with regard to RFS in advanced gastric cancer
Univariate Multivariate
Variable HR 95% CI P HR 95% CI P
Gender F/ M 1.05 0.65 -1 .69 0.86
Age < 60/ ≥60 yr 1.30 0.81- 2.08 0.29
Tumor site 0.58
  body/fundus 0.68 0.31-1.49 0.33
  antrum/fundus, body 0.88 0.45 -1.71 0.70
Tumor size < 5/ ≥5 cm 2.05 1.25 - 3.37 0.005 1.80 1.07 – 3.04 0.027
grade Well/Poorly 0.88 0.40 -1.93 0.75
T stage 0.10
  T3/T2 2.21 0.92-5.30 0.077 0.58
  T4/T2,T3 2.60 1.08 -6.26 0.032 0.75
N stage N0,N1/N2,N3 2.28 1.34-3.87 0.002 0.83
Vascular−/+ 0.91 0.49-1.70 0.77
Perineural−/+ 1.27 0.71-2.25 0.42
Margin−/+ 2.42 1.41-4.15 0.001 2.49 1.44– 4.31 0.001
TNM stage I,II/III,IV 3.10 1.69-5.68 0.000 2.25 1.18 –4.30 0.014
hK6−/+ 2.77 1.41-5.47 0.003 2.09 1.04 –4. 230.039

Liu et al.

Liu et al. Diagnostic Pathology 2013 8:62   doi:10.1186/1746-1596-8-62

Open Data